EKR Therapeutics, Inc. Announces Robert P. Roche Jr. Joins Board of Directors
10/24/2011 10:07:47 AM
BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a privately held specialty pharmaceutical company focused on providing critical care products to the hospital marketplace, has announced the appointment of Robert P. Roche Jr. to the EKR Board of Directors as an Independent Director.
comments powered by